Proactive Investors: CytoDyn Files to Uplist to the Nasdaq, Updates on Coronavirus Trials Jul 17, 2020
Proactive Investors: CytoDyn CEO calls Citron Research report 'false', updates on coronavirus clinical trials Jul 1, 2020
WTNH-New Haven, CT (ABC-affiliate): Yale infectious disease doctor weighs in on HIV drug’s promise for Covid-19 and mask safety Jun 29, 2020
The Atlanta Journal-Constitution: For some with COVID-19, symptoms can linger for weeks, even months Jun 19, 2020
Proactive Investors: CytoDyn expects to exceed 75-patient enrollment in its coronavirus-focused Phase 2 clinical trial Jun 15, 2020
Proactive Investors: CytoDyn continues to works on licensing deals as FDA continues its review on patient data Jun 5, 2020
